103 related articles for article (PubMed ID: 1958393)
1. Alizapride alone or alizapride-dexamethasone compared with metoclopramide-dexamethasone in patients at high risk of acute emesis after cisplatin. A randomized cross-over study.
Pollera CF; Nardi M; Marolla P; Calabresi F
Acta Oncol; 1991; 30(6):725-9. PubMed ID: 1958393
[TBL] [Abstract][Full Text] [Related]
2. A randomized trial comparing alizapride alone or with dexamethasone vs a metoclopramide-dexamethasone combination for emesis induced by moderate-dose cisplatin.
Pollera CF; Nardi M; Marolla P; Carlini P
Cancer Chemother Pharmacol; 1987; 19(4):335-8. PubMed ID: 3297376
[TBL] [Abstract][Full Text] [Related]
3. High-dose intravenous metoclopramide versus combination high-dose metoclopramide and intravenous dexamethasone in preventing cisplatin-induced nausea and emesis: a single-blind crossover comparison of antiemetic efficacy.
Strum SB; McDermed JE; Liponi DF
J Clin Oncol; 1985 Feb; 3(2):245-51. PubMed ID: 4038511
[TBL] [Abstract][Full Text] [Related]
4. Effective control of CMF-related emesis with high-dose dexamethasone: results of a double-blind crossover trial with metoclopramide and placebo.
Pollera CF; Nardi M; Marolla P; Pinnaró P; Terzoli E; Giannarelli D
Am J Clin Oncol; 1989 Dec; 12(6):524-9. PubMed ID: 2589233
[TBL] [Abstract][Full Text] [Related]
5. Activity of a new antiemetic agent: alizapride. A randomized double-blind crossover controlled trial.
Bleiberg H; Gerard B; Dalesio O; Crespeigne N; Rozencweig M
Cancer Chemother Pharmacol; 1988; 22(4):316-20. PubMed ID: 3048762
[TBL] [Abstract][Full Text] [Related]
6. [Phase I study of alizapride in cancer patients treated with cisplatin].
Nicaise C; Rozencweig M; Ortmans M; Frisque C; Bleiberg H
Sem Hop; 1983 Sep; 59(31):2161-5. PubMed ID: 6312589
[TBL] [Abstract][Full Text] [Related]
7. The antiemetic activity of high-dose alizapride and high-dose metoclopramide in patients receiving cancer chemotherapy: a prospective, randomized, double-blind trial.
Joss RA; Galeazzi RL; Bischoff AK; Pirovino M; Ryssel HJ; Brunner KW
Clin Pharmacol Ther; 1986 Jun; 39(6):619-24. PubMed ID: 3519041
[TBL] [Abstract][Full Text] [Related]
8. Randomized open cross-over trial between metoclopramide (MCP) and dexamethazone (DXM) for the prevention of cisplatin-induced nausea and vomiting.
Cognetti F; Pinnarò P; Carlini P; Conti EM; Cortese M; Pollera CF
Eur J Cancer Clin Oncol; 1984 Feb; 20(2):183-7. PubMed ID: 6368241
[TBL] [Abstract][Full Text] [Related]
9. A prospective randomized double-blind crossover study comparing the antiemetic activity of alizapride and metoclopramide in patients receiving cisplatin chemotherapy.
Basurto C; Roila F; Del Favero A; Ballatori E; Minotti V; Tonato M
Cancer Invest; 1988; 6(5):475-9. PubMed ID: 3063335
[TBL] [Abstract][Full Text] [Related]
10. Randomized trial for the control of acute vomiting in cisplatin-treated patients: high-dose metoclopramide with dexamethasone and lorazepam as adjuncts versus high-dose alizapride plus dexamethasone and lorazepam. Study of the incidence of delayed emesis.
Moreno I; Rosell R; Abad-Esteve A; Barnadas A; Carles J; Ribelles N
Oncology; 1991; 48(5):397-402. PubMed ID: 1745488
[TBL] [Abstract][Full Text] [Related]
11. Antiemetic activity of metoclopramide versus alizapride during cancer chemotherapy.
Zambetti M; Bajetta E; Bidoli P; Verusio C
Tumori; 1985 Dec; 71(6):609-14. PubMed ID: 4082295
[TBL] [Abstract][Full Text] [Related]
12. Comparison of three protracted antiemetic regimens for the control of delayed emesis in cisplatin-treated patients.
Moreno I; Rosell R; Abad A; Barnadas A; Carles J; Ribelles N; Solano V; Font A
Eur J Cancer; 1992; 28A(8-9):1344-7. PubMed ID: 1515247
[TBL] [Abstract][Full Text] [Related]
13. Anti-emetic effect of high-dose metoclopramide vs alizapride--a randomised crossover study.
Seng KT; Tiong CE; Hiang TC
Br J Clin Pharmacol; 1994 Sep; 38(3):282-4. PubMed ID: 7826833
[TBL] [Abstract][Full Text] [Related]
14. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
Sorbe BG
Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123
[TBL] [Abstract][Full Text] [Related]
15. Efficacy & tolerability of ondansetron compared to metoclopramide in dose dependent cisplatin-induced delayed emesis.
Bhatia A; Tripathi KD; Sharma M
Indian J Med Res; 2004 Sep; 120(3):183-93. PubMed ID: 15489556
[TBL] [Abstract][Full Text] [Related]
16. [Randomized study of the antiemetic efficacy of alizapride versus alizapride + dexamethasone].
Epifani C; Scognamiglio G; Prete C; Alberio F; Gini G; Valli M
G Ital Oncol; 1990; 10(4):115-9. PubMed ID: 2093079
[TBL] [Abstract][Full Text] [Related]
17. Comparison of ondansetron with metoclopramide in prevention of acute emesis associated with low dose & high dose cisplatin chemotherapy.
Bhatia A; Tripathi KD; Sharma M
Indian J Med Res; 2003 Jul; 118():33-41. PubMed ID: 14748464
[TBL] [Abstract][Full Text] [Related]
18. Improved control of cisplatin-induced emesis with a metoclopramide-dexamethasone combination.
Cognetti F; Pinnaro P; Carlini P; Caporali C; Ruggeri EM; Pollera CF
Cancer Chemother Pharmacol; 1984; 13(3):235-7. PubMed ID: 6541533
[TBL] [Abstract][Full Text] [Related]
19. Comparative effects of intravenously administered alizapride and prochlorperazine in cisplatin-induced emesis.
Roché H; Hyman G; Nahas G; Stoopler M; Ellison R; Desjardins R
Cancer Invest; 1987; 5(2):89-93. PubMed ID: 3607576
[TBL] [Abstract][Full Text] [Related]
20. [Control of the emesis induced by cisplatin in patients with head and neck neoplasms. Randomized study of metoclopramide alizapride and placebo].
Denaro A; Rossi M; Garozzo A; Matera M; Neri V
G Ital Oncol; 1990; 10(1-2):29-34. PubMed ID: 2192985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
